Structural variability of CD44v molecules and reliability of immunodetection of CD44 isoforms using mAbs specific for CD44 variant exon products

American Journal of Pathology

Volumn 154, Issue 1, 1999, Pages 291-300

  Martegani, Marco Paolo ^a   Del Prete, Fabrizio ^a   Gasbarri, Alessandra ^a   Natali, Pier Giorgio ^a   Bartolazzi, Armando ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD44V ANTIGEN; EPITOPE; HERMES ANTIGEN; MONOCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; EXON; FLUORESCENCE; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STRUCTURE; TUMOR CELL; TUMOR GROWTH;

EID: 0032940624     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65275-3     Document Type: Article

References (21)

1. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zoller M: Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 1992, 257:682-685
2. Günthert U, Hofmann M, Rudy W, Reber SZ, Zoller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P: A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991, 65:13-24
3. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I: Interaction between CD44 hyaluronate is directly implicated in the regulation of tumor development. J. Exp Med 1994, 180:53-66
4. Screaton GR, Bell MV, Jackson DG, Cornelis RB, Gerth U, Bell JI: Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 1992, 89:12160-12164
5. Aruffo A, Stamenkovic I, Melnik M, Underhill CB, Seed B: CD44 is the principal cell surface receptor lor hyaluronate. Cell 1990, 61:1303-1313
6. Bartolazzi A, Jackson DG, Bennett K, Aruffo A, Dickinson R, Shields J, Whittle N, Stamenkovic I: Regulation of growth and dissemination of a human lymphoma by CD44 splice variants. J Cell Sci 1995, 108: 1723-1733
7. Bartolazzi A, Nocks A, Aruffo A, Spring F, Stamenkovic I: Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronate. J Cell Biol 1996, 132:1199-1208
8. Bennett KL, Modrell B, Greenfield B, Bartolazzi A, Stamenkovic I, Peach R, Jackson DJ, Spring F, Aruffo A: Relation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J Cell Biol 1995, 131:1623-1633
9. G̈unthert U. CD44 in malignant disorders: Curr Top Microbiol Immunol 1996, 213:271-285
10. Lesley J, Hyman R: Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med 1995, 182:431-437
11. Skelton TP, Zeng C, Nocks A, Stamenkovic I: Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J Cell Biol 1998, 140:431-446
12. Koopman G, Heider KH, Horst E, Adolf GR, van den Berg F, Ponta H, Herrlich P, Pals ST: Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 1993, 177:897-8904
13. Naor D, Vogt Sionov R, Ish-Shalom D: CD44: structure, function, and association with the malignant process: Adv Cancer Res 1997, 71: 241-319
14. Matsumura Y, Tarin D: Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 1992, 340:1053-1058
15. Sy MS, Guo YJ, Stamenkovic I: Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J Exp Med 1992, 176:623-627
16. Katoh S, McCarthy JB, Kincade PW: Characterization of soluble CD44 in the circulation of mice. Levels are affected by immune activity and tumor growth. J Immunol 1994, 153:3440-3449
17. Natali PG, Nicotra MR, Bartolazzi A, Cavaliere R, Bigotti A: Integrin expression in cutaneous malignant melanoma: association of the α3β1 heterodimer with tumor progression. Int J Cancer 1993, 54: 68-72
18. Antsee DJ, Gardner B, Spring FA, Holmes CH, Simpson KL, Parsons SF, Mallison G, Yousaf SM, Judson PA: New monoclonal antibodies in CD44 and CD58: their use to quantify CD44 and CD58 on normal human erythrocytes and to compare the distribution of CD44 and CD58 in human tissues. Immunology 1991, 74:197-205
19. Jackson DG, Buckley J, Bell JI: Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 1992, 267:4732-4739
20. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR: Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989, 77:51-59
21. Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C. Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF: Leucocyte Typing V. Oxford, Oxford University Press, 1995, pp 1713-1719